Integrative Proteomic Characterization of Human Lung AdenocarcinomaJun‐Yu Xu, Minjia Tan, Yiming Ma et al.|Cell|2020Cited by 634
CLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trialJia Liu, Lin Shen, Jianwei Yang et al.|Nature Medicine|2025Cited by 29